摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

O2-methyl-L-6-deoxy-mannose | 29839-06-3

中文名称
——
中文别名
——
英文名称
O2-methyl-L-6-deoxy-mannose
英文别名
O2-Methyl-L-rhamnose;L-manno-3,4,5-Trihydroxy-2-methoxy-hexanal;O2-Methyl-6-desoxy-L-mannose;2-o-Methyl-l-rhamnose;(2R,3R,4S,5S)-3,4,5-trihydroxy-2-methoxyhexanal
<i>O</i><sup>2</sup>-methyl-<i>L</i>-6-deoxy-mannose化学式
CAS
29839-06-3
化学式
C7H14O5
mdl
——
分子量
178.185
InChiKey
VCUILRLOJMHSMR-AXMZGBSTSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    -1.8
  • 重原子数:
    12
  • 可旋转键数:
    5
  • 环数:
    0.0
  • sp3杂化的碳原子比例:
    0.86
  • 拓扑面积:
    87
  • 氢给体数:
    3
  • 氢受体数:
    5

反应信息

  • 作为反应物:
    描述:
    O2-methyl-L-6-deoxy-mannose甲醇 作用下, 生成 O2-methyl-L-rhamnonic acid amide
    参考文献:
    名称:
    Methylene Derivatives of L-Rhamnose1
    摘要:
    DOI:
    10.1021/ja01606a039
  • 作为产物:
    描述:
    alkaline earth salt of/the/ methylsulfuric acid 在 盐酸 作用下, 生成 O2-methyl-L-6-deoxy-mannose
    参考文献:
    名称:
    2-METHYL-l-RHAMNOSE AND 2-METHYL-d-FUCOSE AND THEIR BEARING ON THE CONFIGURATION OF DIGITALOSE
    摘要:
    DOI:
    10.1021/jo01214a009
点击查看最新优质反应信息

文献信息

  • ANTIBIOTIC FIIRV 104/18 COMPLEX AND THE ISOLATED INDIVIDUAL FACTORS THEREOF
    申请人:Fondazione Istituto Insubrico di Ricerca per la Vita
    公开号:EP3383405A1
    公开(公告)日:2018-10-10
  • [EN] ANTIBIOTIC FIIRV 104/18 COMPLEX AND THE ISOLATED INDIVIDUAL FACTORS THEREOF<br/>[FR] COMPLEXE ANTIBIOTIQUE FIIRV 104/18 ET FACTEURS INDIVIDUELS ISOLÉS DE CE DERNIER
    申请人:FOND ST INSUBRICO DI RICERCA PER LA VITA
    公开号:WO2017093114A1
    公开(公告)日:2017-06-08
    An antibiotic FIIRV 104/18 complex comprising factors F793, F795, F797, F813 and F683, of formula (I), wherein R represents a glycosidic radical as defined in the specification, the isolated individual factors, a method for their production by cultivation of Dactylosporangium FIIRV sp. 104/18 DSM 32068 under aerobic conditions, and pharmaceutical formulations containinig them as active ingredient and their use in the treatment of bacterial infections, caused by bacteria of at least one of the genera Enterococci, Streptococci, Staphylococci and Moraxella, including bacteria of multi resistant strains, in particular Staphylococcus spp., Streptococcus spp, and Enterococcus spp. resistant to methicillin and/or vancomycin.
查看更多